A. J. Hoitsma

1.4k total citations
38 papers, 870 citations indexed

About

A. J. Hoitsma is a scholar working on Transplantation, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, A. J. Hoitsma has authored 38 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Transplantation, 10 papers in Public Health, Environmental and Occupational Health and 9 papers in Epidemiology. Recurrent topics in A. J. Hoitsma's work include Renal Transplantation Outcomes and Treatments (21 papers), Neurological Complications and Syndromes (8 papers) and Organ Donation and Transplantation (7 papers). A. J. Hoitsma is often cited by papers focused on Renal Transplantation Outcomes and Treatments (21 papers), Neurological Complications and Syndromes (8 papers) and Organ Donation and Transplantation (7 papers). A. J. Hoitsma collaborates with scholars based in Netherlands, United States and Belgium. A. J. Hoitsma's co-authors include Willem Weimar, Ronald J. Hené, Andrew Nicholls, Gert A. Verpooten, Jean‐Paul Squifflet, Yves Vanrenterghem, Roy Bullingham, Michael Hale, Jack F.M. Wetzels and J. S. F. Gimbrère and has published in prestigious journals such as Journal of Clinical Microbiology, European Urology and Transplantation.

In The Last Decade

A. J. Hoitsma

37 papers receiving 842 citations

Peers

Countries citing papers authored by A. J. Hoitsma

Since Specialization

Citations

This map shows the geographic impact of A. J. Hoitsma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. J. Hoitsma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. J. Hoitsma more than expected).

Fields of papers citing papers by A. J. Hoitsma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. J. Hoitsma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. J. Hoitsma. The network helps show where A. J. Hoitsma may publish in the future.

Co-authorship network of co-authors of A. J. Hoitsma

This figure shows the co-authorship network connecting the top 25 collaborators of A. J. Hoitsma. A scholar is included among the top collaborators of A. J. Hoitsma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. J. Hoitsma. A. J. Hoitsma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Shared Decision-Making in Kidney Patients: Involvement in Decisions Regarding the Quality of Deceased Donor Kidneys 2018 ·Transplantation Proceedings ·(unknown), A. J. Hoitsma, Reinier Timman, Ronald Zwart, (unknown), (unknown), Jan J.V. Busschbach, Sohal Y. Ismail	9
2	Reactivation of Latent HPV Infections After Renal Transplantation 2016 ·American Journal of Transplantation ·F. Hinten, Luuk B. Hilbrands, K.A.P. Meeuwis, Joanna IntHout, Wim Quint, A. J. Hoitsma, Leon F.A.G. Massuger, Willem J. G. Melchers, Joanne A. de Hullu	39
3	Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry 2014 ·Nephrology Dialysis Transplantation ·(unknown), Karlijn J. van Stralen, C. Wanner, Gema Ariceta, James Heaf, Anna Bjerre, Ragnar Pálsson, (unknown), A. J. Hoitsma, Pietro Ravani, Franz Schaefer, Kitty J. Jager	47
4	Reduced Cutaneous Squamous Cell Carcinoma after Conversion to Sirolimus: A 2-Year Prospective Open-Label Multicenter Trial 2012 ·American Journal of Transplantation ·Johan W. de Fijter, (unknown), Paul Harden, A. J. Hoitsma, Charlotte M. Proby, Ron Wolterbeek, Jan Nico Bouwes Bavinck	2
5	Reduced rate of cutaneous squamous cell carcinoma in a randomised, prospective, multi-centre controlled trial of conversion to sirolimus-based immunosuppression: The RESCUE Trial 2011 ·Transplant International ·Paul Harden, (unknown), (unknown), Charlotte M. Proby, A. J. Hoitsma, (unknown), (unknown)	2
6	Is standardized cardiac assessment of asymptomatic high-risk renal transplant candidates beneficial? 2011 ·Nephrology Dialysis Transplantation ·Jeroen Aalten, (unknown), (unknown), A. J. Hoitsma	15
7	Continuation of cinacalcet immediately after renal transplantation: a prospective cohort study 2010 ·Clinical Nephrology ·Jeroen Aalten, J F M Wetzels, A. J. Hoitsma	5
8	Transition to the adult nephrologist does not induce acute renal transplant rejection 2009 ·Nephrology Dialysis Transplantation ·(unknown), (unknown), Elisabeth A. M. Cornelissen, Fréderike J. Bemelman, A. J. Hoitsma, Ronald B. Geskus, Antonia H. Bouts, Jaap W. Groothoff	22
9	[Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects]. 2000 ·PubMed ·(unknown), Luuk B. Hilbrands, (unknown), R. J. Hené, Maarten H. L. Christiaans, A. J. Hoitsma	1
10	The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation* 1998 ·Clinical Pharmacology & Therapeutics ·Michael Hale, Andrew Nicholls, Roy Bullingham, Ronald J. Hené, A. J. Hoitsma, Jean‐Paul Squifflet, Willem Weimar, Yves Vanrenterghem, (unknown), Gert A. Verpooten	339
11	Urological Complications in Renal Transplantation 1997 ·European Urology ·(unknown), E.J.H. Meuleman, G.O.N. Oosterhof, A. J. Hoitsma	34
12	Randomized trial of misoprostol in patients with chronic renal transplant rejection 1996 ·Transplant International ·Luuk B. Hilbrands, J. Rischen-Vos, Ronald J. Hené, Willem Weimar, Karen E. Assmann, A. J. Hoitsma	2
13	Doppler spectrum analysis in the differential diagnosis of renal transplant dysfunction 1996 ·Clinical Transplantation ·J. W. S. Merkus, W. N. J. C. van Asten, A. J. Hoitsma, (unknown), R. A. P. Koene, S.H. Skotnicki	6
14	Evaluation of the Banff criteria for the histological diagnosis of rejection in renal allograft biopsies 1995 ·Transplantation ·A. J. Hoitsma, R A Koene, M.J.J.T. Bogman, (unknown)	1
15	Diagnosis and Treatment of Urological Complications in Kidney Transplantation 1992 ·Urologia Internationalis ·G.O.N. Oosterhof, A. J. Hoitsma, J. Alfred Witjes, F.M.J. Debruyne	26
16	Adrenocortical function: An indicator of severity of disease and survival in chronic critically ill patients 1992 ·Intensive Care Medicine ·Lambert F. R. Span, A. R. M. M. Hermus, A. K. M. Bartelink, A. J. Hoitsma, J. S. F. Gimbrère, A. G. H. Smals, P. W. C. Kloppenborg	109
17	Diagnostic value of monocyte/macrophage (WT14) staining in renal allograft biopsies. 1991 ·PubMed ·M.J.J.T. Bogman, (unknown), A. J. Hoitsma, M C de Jong, W.J.M. Tax, K.J.M. Assmann, R A Koene	4
18	Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin 1989 ·Transplant International ·Frank H. Bosch, A. J. Hoitsma, (unknown), Anton M. van Loon, R. A. P. Koene	12
19	Cytomegalovirus infection and disease in renal transplant patients treated with cyclosporin: A prospective study 1989 ·Transplant International ·Frank H. Bosch, A. J. Hoitsma, (unknown), Anton M. van Loon, R. A. P. Koene	2
20	Hemolytic‐uremic syndrome during cyclosporine immunosuppression in renal allograft recipients 1987 ·Clinical Transplantation ·J. H. M. Berden, (unknown), (unknown), A. J. Hoitsma, (unknown), L.A.H. Monnens, R. A. P. Koene	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact